Introduction
============

Chest pain is predominant symptoms of acute myocardial infarction (AMI). However, approximately one-third of AMI patients presented to hospital without typical chest pain.^\[[@R1]\]^ Previous studies have reported atypical presentation was independently associated with higher in-hospital mortality risk.^\[[@R2]--[@R7]\]^ AMI is traditionally classified into ST-segment elevation myocardial infarction (STEMI) and non-ST segment elevation myocardial infarction (NSTEMI) based on ST-segment elevation on electrocardiogram, and approximately 70% patients with acute coronary syndrome presented without ST-elevation.^\[[@R8]\]^

There is significant difference in pathological process between STEMI and NSTEMI, which may lead to difference in symptoms. However, few studies up to date have reported symptoms of patients with NSTEMI in details, especially among Asian patients. The objective of this study was to describe and compare symptoms and presenting characteristics of NSTEMI *vs*. STEMI patients.

Methods
=======

Ethical approval
----------------

This project was approved by the institutional review board central committee at Fuwai Hospital, National Center for Cardiovascular Diseases, China. The study was in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the *Declaration of Helsinki* 1975, as revised in 2000. Written informed consent was obtained from eligible patients before registration.

Study population
----------------

All patients included in this study were from China Acute Myocardial Infarction (CAMI) Registry. Details on trial designs have been described previously.^\[[@R9]\]^ Briefly, CAMI registry was a prospective multi-center registry conducted in China. Eligible patients were diagnosed with AMI according to the third Universal Definition for Myocardial Infarction, in which AMI was classified into type 1, 2, 3, 4a, 4b, 5.^\[[@R1]\]^ CAMI registry included patients with type 1, 2, 3 and type 4b, 4c and excluded patients with type 4a and type 5. For our study, we extracted data from CAMI database between January 1st, 2013 to September 30th, 2014 and identified a cohort of 26,082 patients. We excluded patients with missing or invalid data on in-hospital admission diagnosis (STEMI or NSTEMI), age, sex, BMI and finally, included 21,994 patients \[Figure [1](#F1){ref-type="fig"}\].

![Study population. From January 2013 to September 2014, a total of 26,082 patients with AMI were registered, after excluding patients with missing or invalid data on admission diagnosis (STEMI or NSTEMI), BMI, age, gender, we finally included 21,994 patients (STEMI: 16,315, NSTEMI: 5679).](cm9-132-519-g001){#F1}

Data collection and definition
------------------------------

We extracted data on patient demographics, medical history, symptom on admission, time to hospital, diagnosis, and so on from CAMI database. Standardized questionnaire was used to collect data on symptomatology. Symptomatology assessment included persistent chest pain (≥20 min), dyspnea, nausea and vomiting, diaphoresis, syncope and incontinence. Atypical symptoms were defined as clinical presentation without chest pain. Chest distress is defined as a sensation of chest pressure or tightness. According to third universal definition of MI, patients who develop ST elevation in two contiguous leads were classified into STEMI group. In contrast, patients without ST elevation were classified into NSTEMI group.

Statistical analysis
--------------------

We used mean ± standard deviation (SD) or median (25th and 75th percentiles) to present continuous variables, and Counts (frequencies) to present categorical variables. Student *t* tests or rank tests were used to compare continuous variables, and Chi-square tests were used to compare categorical variables. A *P* value less than 0.05 was of statistical significance unless otherwise indicated. Multivariable logistic regression model was used to explore independent predictors of atypical symptoms. Candidate variables fitted in the model were based on previous reports and clinicians experience including: age, sex, diabetes, type of MI, anterior wall MI, Killip classification, heart rate, blood pressure, prodromal symptoms, body mass index (BMI), hypertension, smoking status, prior MI, prior percutaneous coronary intervention (PCI), prior coronary artery bypass graft (CABG), renal failure, prior angina, hyperlipidemia, history of family coronary artery disease (CAD), prior stroke and prior heart failure (HF). After stepwise selection, those variables with *P* \< 0.05 were retained in the model. All analysis was performed with SAS 9.4 software (SAS Institute, USA).

Results
=======

Baseline characteristics
------------------------

Among 21,994 patients included in our study, a total of 16,315 (74.2%) patients had STEMI and the remaining 5679 (25.8%) patients had NSTEMI. Table [1](#T1){ref-type="table"} showed baseline characteristics between 2 groups. Compared with patients with STEMI, NSTEMI patients were older (mean age: 65.6 *vs*. 62.0 years, *P* \< 0.0001) and more likely to be females (31.8% *vs*. 23.6%, *P* \< 0.0001). NSTEMI patients were also more likely to have diabetes (24.7% *vs*. 18.7%, *P* \< 0.0001), prior MI (11.9% *vs*. 5.9%, *P* \< 0.0001), prior HF (5.9% *vs*. 1.5%, *P* \< 0.0001), prior PCI (5.0% *vs*. 3.1%, *P* \< 0.0001), prior CABG (0.9% *vs*. 0.3%, *P* \< 0.0001), hypertension (59.5% *vs*. 48.7%, *P* \< 0.0001), hyperlipidemia (8.4% *vs*. 6.8%, *P* \< 0.0001) and nonsmokers (51.9% *vs*. 43.1%, *P* \< 0.0001).

###### 

Baseline characteristics of patients with STEMI *vs*. NSTEMI.
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Clinical symptoms by MI type
----------------------------

A total of 111 patients in NSTEMI group and 197 patients in STEMI group presented without symptoms (2% *vs*. 1.2%, *P* = 0.0001) \[Table [2](#T2){ref-type="table"}\]. Most common symptoms in both NSTEMI and STEMI group were persistent precordial chest pain, diaphoresis, chest distress, and radiation pain. The proportion of persistent precordial chest pain (54.3% *vs*. 71.4%, *P* \< 0.0001), diaphoresis **(**48.6% *vs*. 70.0%, *P* \< 0.0001), radiation pain (26.4% *vs*. 33.8%, *P* \< 0.0001), nausea or vomiting (19.1% *vs*. 30.1%, *P* \< 0.0001), dysphoria (3.6% *vs*. 4.4%, *P* = 0.0079), syncope (2.3% *vs*. 2.9%, *P* = 0.0116) were lower among NSTEMI patients compared with STEMI patients. The proportion of chest distress (42.4% *vs*. 38.3%, *P* \< 0.0001), shortness of breath (24.5% *vs*. 21.2%, *P* \< 0.0001), palpitation (14.5% *vs*. 13.0%, *P* = 0.0055) and recurrent angina (5.9% *vs*. 2.6%, *P* \< 0.0001) were higher in NSTEMI group compared with STEMI group.

###### 

Clinical symptoms of patients with STEMI *vs*. NSTEMI.
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Time to hospital by MI type
---------------------------

Table [3](#T3){ref-type="table"} showed time to hospital among patients with NSTEMI *vs*. STEMI. More patients in NSTEMI group presented to hospital 1 to 7 days (41.5% *vs*. 23.8%) or 12 to 24 h (13.9% *vs*. 10.3%) after presentation, fewer patients in NSTEMI group presented to hospital less than 3 h (14.5% *vs*. 23.5%), *P* value less than 0.0001.

###### 

Time to hospital of patients with NSTEMI *vs*. STEMI, *n* (%).
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Independent predictors of atypical symptoms
-------------------------------------------

Multivariable logistic model was used to explore independent predictors of atypical symptoms. After stepwise selection, the following variables were identified as independent predictors of atypical symptom and were shown in Table [4](#T4){ref-type="table"}: age, DM, NSTEMI, higher Killip classification level, heart rate, systolic blood pressure and the presence of predromal symptoms. Of note, after adjustment for confounders including age, sex, diabetes, type of MI, anterior wall MI, Killip classification, heart rate, blood pressure, predromal symptoms, BMI, hypertension, smoking status, PCI, prior CABG, renal failure, prior angina, hyperlipidemia, family history of CAD, prior stroke, prior HF, type of MI (NSTEMI *vs*. STEMI) was still associated with atypical symptoms. NSTEMI independently predicted presentation of atypical symtom (odds ratio (OR): 1.974, 95%confidence interval (CI): 1.849-2.107).

###### 

Independent predictors of atypical symptoms.
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Discussion
==========

In the analysis of a large-scale prospective registry, we found that compared with patients with STEMI, fewer patients with NSTEMI presented with persistent chest pain, diaphoresis and radiation chest pain and more patients presented with chest distress. Time from symptom onset to hospital was longer among NSTEMI patients.

In multivariable analysis, NSTEMI was an independent predictor of atypical symptom.

There were several large-scale previous studies describing and comparing clinical characteristics of AMI patients with *vs*. without typical chest pain. These studies used data from different registries including Korea Acute Myocardial Infarction Registry (KAMIR) registry,^\[[@R2]\]^ The Global Registry of Acute Coronary Events (GRACE) registry,^\[[@R3]\]^ National registry of myocardial infarction (NRMI)^\[[@R4],[@R10]\]^ and Japanese registry of acute Myocardial INfarction diagnosed by Universal dEfiniTion (J-MINUET).^\[[@R5]\]^ These studies showed that painless STEMI had higher in-hospital mortality than painful STEMI,^\[[@R2],[@R3]\]^ presentation without chest pain were more common among NSTEMI patients and proportion of ST-segment elevation was less common among patients without chest pain.^\[[@R4],[@R5]\]^ Another large-scale registry-based study enrolled 1,143,513 patients with MI from 1977 hospitals and found patients with chest pain were more likely to present STEMI and those without chest pain were more likely to present NSTEMI. Although this study didn't directly compare symptoms between STEMI and NSTEMI patients, it indicated that NSTEMI patients were more likely to present without typical chest pain.^\[[@R11]\]^ However, these studies had several major limitations: symptoms were not compared between STEMI and NSTEMI patients, and details of presenting complaints among those without chest pain (ie, dyspnea, nausea, and so on) were not provided. Our study is the first large-scale study describing and comparing symptoms of NSTEMI *vs*. STEMI in details and is useful to enhance clinicians' awareness of wide spectrum of symptoms among NSTEMI patients.

There are differences in AMI characteristics between China and other countries. In Europe and USA, NSTEMI are more common than STEMI while in China STEMI is still the dominant type of AMI.^\[[@R12]\]^ However, the proportion of NSTEMI is increasing, highlighting the importance to learn more about NSTEMI symptoms. Second, prehospital delay time is longer in China compared with other countries: decision time (from symptom onset to decision to seek medical help) in China was 130 min, which was longer than that in other countries (UK: 121 min; Canada: 98 min; Sweden: 110 min).^\[[@R13]\]^ Of note, seeking non-emergent medical care was the most popular action when no chest pain occurs.^\[[@R14]\]^ In summary, these data as well as our results highlighted that improvement in the management of AMI is still needed. First, patients should be educated more about possible symptoms of AMI, particular atypical symptoms in order to reduce prehospital patient delay and receive medical care as soon as possible. In addition, clinicians should increase the awareness of NSTEMI, particularly for those with atypical symptoms including chest distress and non-ST elevation on ECG.

Several factors may be associated with atypical symptoms among NSTEMI patients: It is generally thought that patients with NSTEMI had smaller infarct size than STEMI patients, and the infarct does not involve full thickness of the myocardium or epicardium. A magnetic resonance-based study also indicated that NSTEMI patients had smaller infarct size and area at risk, as well as less reperfusion injury than STEMI patients.^\[[@R10]\]^ When a heart attack occurs, the sensation of pain started with activation of afferent nerve, which predominantly locates in outer epicardium.^\[[@R15]\]^ As discussed above, NSTEMI patients may involve less epicardium and afferent nerve activation, and therefore perceive less pain but more atypical symptoms.^\[[@R3]\]^

Another major finding of our study is that NSTEMI patients had longer time from symptom onset to hospital, which was also demonstrated in several other large-scale studies. Data from GRACE registry indicated that NSTEMI patients had longer pre-hospital patient delay than STEMI patients (3.1 h *vs*. 2.5 h, *P* \< 0.05), irrespective or geographic region.^\[[@R16]\]^ Miyachi *et al* used data from Tokyo CCU network database and found that NSTEMI patients had higher onset-to-door time (233 *vs*. 165 min, *P* \< 0.001) and higher door to balloon time (145 *vs*. 60 min, *P* \< 0.001) than STEMI patients.^\[[@R17]\]^ In addition, PCI-related delay was also longer among NSTEMI patients (32.9 *vs*. 3.5 min, *P* \< 0.001).^\[[@R18]\]^

Possible explanations for longer patient delay include: Compared with patients with STEMI, more patients with NSTEMI had prior angina pectoris^\[[@R19]\]^ and were accustomed to ischemic symptoms. Therefore, they were less likely to identify symptoms associated with new-onset AMI. In addition, consistent with our results, many previous studies demonstrated that patients with NSTEMI tend to be older and have more comorbidities including heart failure, stroke, and diabetes.^\[[@R18],[@R20]--[@R22]\]^ Identification of cardiac origin symptoms may be masked by these chronic diseases and therefore leading to pre-hospital delay. Our results confirmed that prompt recognition of AMI symptoms and signs were of clinical significance for reducing pre-hospital patient delay and improving outcome for NSTEMI patients in particular.

Our study had large sample size and detailed description of symptoms particular for those patients without chest pain. Diagnostic criteria were clear and well accepted. However, there are several limitations of our study: all participants were from China, it remains unclear whether there is ethnic difference in symptoms of AMI. Our study did not account for follow-up data. Whether NSTEMI has impact on short or long-term prognosis needs further investigation. Finally, our study was an observational non-randomized registry based study which may subject to selection bias related to this type of clinical investigation.

Compared with patients with STEMI, those with NSTEMI were less likely to present with typical chest pain, diaphoresis and radiation chest pain and more likely to have chest distress. Patients with NSTEMI also had longer time to hospital than patients with NSTEMI. Our results were useful for both clinicians and patients to gain deeper understanding of symptoms of NSTEMI and reduce pre-hospital patient delay.
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